Cancer Cell Paper Identifies Avidity Enhancement As New Strategy for Improving CAR T Therapy for Acute Myeloid Leukemia

/PRNewswire/ -- LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced...

Related Keywords

Massachusetts ,United States ,Amsterdam ,Noord Holland ,Netherlands ,Marcelav Maus ,Andrea Candelli ,Maus Lab ,Professor Of Medicine At Harvard Medical School ,Cancer Cell ,Chimeric Antigen Receptor ,Acute Myeloid Leukemia ,Associate Professor ,Harvard Medical School ,Massachusetts General ,Cell Avidity Analyzer ,Chief Scientific Officer ,Movi Cell Avidity Analyzer ,Lumicks ,